Mural Oncology
Jeff Roncal is an experienced pharmaceutical professional currently serving as Vice President and Head of Drug Safety and Pharmacovigilance at Mural Oncology since July 2024. Previously, Roncal held the position of Vice President at Editas Medicine and served as Vice President and Head of Safety and Pharmacovigilance at Jounce Therapeutics, Inc. with an extensive background in drug safety across various organizations, including roles at Shire, AbbVie, Astellas Pharma, Otsuka America Pharmaceutical, Inc., URL Pharma, MedImmune, and Bracco Diagnostics. Roncal earned a Doctor of Medicine degree from Angeles University Foundation and a Bachelor of Science in Medical Technology from the University of Santo Tomas.
This person is not in any teams